Skip to main content
Interview with the Innovators

PYLARIFY Imaging in High-Risk Prostate Cancer

Videos
Steven Rowe, MD, PhD
Radiology and Radiological Science
Johns Hopkins Medicine,
Baltimore, MD
Dr Neal Shore emphasizes the importance of accurate staging of prostate cancer and how PYLARIFY® (piflufolastat F 18) can improve treatment decision-making in patients with prostate cancer.

Related Articles